These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 19727388)

  • 1. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.
    Wozniak KL; Ravi S; Macias S; Young ML; Olszewski MA; Steele C; Wormley FL
    PLoS One; 2009 Sep; 4(9):e6854. PubMed ID: 19727388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.
    Hardison SE; Herrera G; Young ML; Hole CR; Wozniak KL; Wormley FL
    J Immunol; 2012 Oct; 189(8):4060-8. PubMed ID: 22984078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis.
    Campuzano A; Castro-Lopez N; Martinez AJ; Olszewski MA; Ganguly A; Leopold Wager C; Hung CY; Wormley FL
    mBio; 2020 Jan; 11(1):. PubMed ID: 31911495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.
    Wozniak KL; Young ML; Wormley FL
    Clin Vaccine Immunol; 2011 May; 18(5):717-23. PubMed ID: 21450975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of IL-17A on resolution of pulmonary C. neoformans infection.
    Wozniak KL; Hardison SE; Kolls JK; Wormley FL
    PLoS One; 2011 Feb; 6(2):e17204. PubMed ID: 21359196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection.
    Wozniak KL; Hole CR; Yano J; Fidel PL; Wormley FL
    Microbiology (Reading); 2014 Jul; 160(Pt 7):1440-1452. PubMed ID: 24760968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.
    Hardison SE; Wozniak KL; Kolls JK; Wormley FL
    Infect Immun; 2010 Dec; 78(12):5341-51. PubMed ID: 20921149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.
    Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Wormley FL
    J Immunol; 2014 Oct; 193(8):4060-71. PubMed ID: 25200956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
    Wormley FL; Cox GM; Perfect JR
    Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins.
    Young M; Macias S; Thomas D; Wormley FL
    Proteomics; 2009 May; 9(9):2578-88. PubMed ID: 19343717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by γδ T cells.
    Wozniak KL; Kolls JK; Wormley FL
    BMC Immunol; 2012 Dec; 13():65. PubMed ID: 23216912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain.
    Wormley FL; Perfect JR; Steele C; Cox GM
    Infect Immun; 2007 Mar; 75(3):1453-62. PubMed ID: 17210668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection.
    Hardison SE; Ravi S; Wozniak KL; Young ML; Olszewski MA; Wormley FL
    Am J Pathol; 2010 Feb; 176(2):774-85. PubMed ID: 20056835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Broad-Spectrum Protective Immunity against Disparate
    Van Dyke MCC; Chaturvedi AK; Hardison SE; Leopold Wager CM; Castro-Lopez N; Hole CR; Wozniak KL; Wormley FL
    Front Immunol; 2017; 8():1359. PubMed ID: 29163469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection.
    Jain AV; Zhang Y; Fields WB; McNamara DA; Choe MY; Chen GH; Erb-Downward J; Osterholzer JJ; Toews GB; Huffnagle GB; Olszewski MA
    Infect Immun; 2009 Dec; 77(12):5389-99. PubMed ID: 19752036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.
    Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Mueller M; Wormley FL
    Infect Immun; 2015 Dec; 83(12):4513-27. PubMed ID: 26351277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
    Upadhya R; Lam WC; Maybruck B; Specht CA; Levitz SM; Lodge JK
    mBio; 2016 May; 7(3):. PubMed ID: 27165801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection.
    Olszewski MA; Huffnagle GB; McDonald RA; Lindell DM; Moore BB; Cook DN; Toews GB
    J Immunol; 2000 Dec; 165(11):6429-36. PubMed ID: 11086082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production.
    Murdock BJ; Huffnagle GB; Olszewski MA; Osterholzer JJ
    Infect Immun; 2014 Mar; 82(3):937-48. PubMed ID: 24324191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection.
    Guillot L; Carroll SF; Homer R; Qureshi ST
    Infect Immun; 2008 Oct; 76(10):4745-56. PubMed ID: 18678664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.